Bavarian Nordic A/S has announced receipt of a $25 million milestone payment from the US government in connection with the scaling up of production of its smallpox vaccine, Imvamune, for delivery to the US national strategic stockpile. ---Subscribe to MedNous to access this article--- Company News Finance, Grants, Deals
